We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Protein Identified That Maintains the Undifferentiated Morphology of Embryonic Stem Cells

By LabMedica International staff writers
Posted on 05 Nov 2012
A recent paper identified a protein called Utf1 (undifferentiated embryonic cell transcription factor 1) as being a critical to the molecular processes that maintain the undifferentiated morphology of embryonic stem cells.

Utf1 is expressed mainly in embryonic stem cells, is regulated by Oct-3/4 (octamer-binding transcription factor 3/4), and promotes rapid cell proliferation. More...
Oct-4 also known as POU5F1 (POU domain, class 5, transcription factor 1) is a protein critically involved in the self-renewal of undifferentiated embryonic stem cells. As such, it is frequently used as a marker for undifferentiated cells. Oct-4 expression is closely regulated, as too much or too little will cause differentiation of the cells.

The interaction of the factors that coordinate the bivalent chromatin state of embryonic stems cells so they can undergo rapid self-renewal while retaining pluripotency is only poorly understood. To shed light on these factors investigators at the Carnegie Institution for Science (Baltimore, MD, USA) used a combination of genetic, protein-oriented, and physiological approaches to study mouse embryonic stem cells.

They reported in the October 26, 2012, online edition of the journal Cell that Utf1 took part in three diverse molecular processes. First, it maintained the balance between the activation and deactivation of the genes required to direct the cell toward differentiation. Simultaneously, it inserted a molecular tag for degradation onto certain messenger RNAs. In addition, it inhibited a genetic feedback loop that normally prevents cellular proliferation, allowing this process to go forward with the rapidity that is characteristic of embryonic stem cells.

"We are slowly but surely growing to understand the physiology of embryonic stem cells," said senior author Dr. Yixian Zheng, professor of embryology at the Carnegie Institution for Science. "It is crucial that we continue to carrying out basic research on how these cells function."

Related Links:
Carnegie Institution for Science



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Immunofluorescence Analyzer
IFA System
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.